Exhibit 99.1
Tutogen Medical,
Inc. Announces New and Expanded
Tissue Sourcing Agreements
For
Immediate Release
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contacts:
|
|
|
|
|
|
|
|
|
|
|
|
L. Robert Johnston, Jr. |
|
|
|
Lytham Partners, LLC |
|
|
|
|
|
Chief Financial Officer |
|
|
|
Joe Diaz |
|
|
|
|
|
Tutogen Medical, Inc. |
|
|
|
Joe Dorame |
|
|
|
|
|
386-462-0402 |
|
|
|
Robert Blum |
|
|
|
|
|
bjohnston@tutogen.com |
|
|
|
602-889-9700 |
|
|
ALACHUA, FLORIDA – November 14, 2007 —
Tutogen Medical, Inc. (AMEX: TTG), a leading manufacturer of
sterile biological implant products made from human
(allograft) and animal (xenograft) tissue, announced
today that it has entered into a tissue supply agreement with the
University of Miami Tissue Bank and has extended its existing
tissue supply agreement with AlloSource, Inc.
Under
the terms of these new five-year agreements, the University of
Miami Tissue Bank and AlloSource will provide Tutogen with various
human tissues used in Tutogen dental, spinal and soft tissue repair
product lines.
Guy
Mayer, president and chief executive officer of Tutogen Medical,
commented, “We are very pleased to partner with such
prestigious and well respected organizations as the University of
Miami Tissue Bank and AlloSource, Inc. We share their commitment to
improving the health and quality of life for our implant
recipients. These new and expanded agreements, along with several
other tissue sourcing agreements rec
